ORIGINAL RESEARCH article
Front. Med.
Sec. Gastroenterology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1549901
This article is part of the Research TopicChronic Atrophic Gastritis: Pathogenesis, Diagnostic Challenges, and Gastric Cancer RiskView all 6 articles
Construction and validation of Nomogram model for prognosis of gastritis patients based on baseline data and inflammatory and infectious markers
Provisionally accepted- The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Gastritis, a global inflammatory disorder, progresses from symptomatic discomfort to potentially malignant changes. Existing staging systems (e.g., OLGA) focus on cancer risk but ignore modifiable factors like inflammation markers and H. pylori infection. We developed a Nomogram model based on baseline data, inflammatory markers and infectious pathogens for predicting the prognosis of gastritis patients and validating it. Methods: Retrospectively collect the clinical data of patients diagnosed with gastritis, including baseline characteristics, inflammatory markers, and pathogenic infection test results. Univariate and multivariate analyses were performed to identify independent risk factors associated with the prognosis of gastritis patients, based on which a Nomogram prediction model was constructed. The model's accuracy, calibration, and discriminative ability were internally validated using the concordance index (C-index), calibration curve, and the area under the receiver operating characteristic curve (AUC). Results: Among the 185 patients in the training set, 43 (23.24%) had poor treatment outcomes, while in the validation set of 79 patients, 18 (22.78%) exhibited poor treatment outcomes. No statistically significant differences were observed between the training and validation sets in terms of the incidence of poor treatment outcomes, baseline characteristics, or inflammatory and infectious markers parameters (P>0.05).Univariate analysis revealed significant differences (P<0.05) between the poor-outcome and favorable-outcome groups in dietary score, white blood cell count, neutrophil percentage, lymphocyte percentage, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), serum albumin level, and Helicobacter pylori infection status. Multivariate logistic regression analysis identified dietary score, neutrophil proportion, CRP, ESR, serum albumin level, and Helicobacter pylori infection as independent risk factors for poor endoscopic treatment outcome (P<0.05). Subsequently, a nomogram prediction model was constructed. The model demonstrated good calibration and fit between predicted and actual outcomes in both the training and validation sets. ROC curve analysis showed that the nomogram model achieved AUC values of 0.808 in the training set and 0.800 in the validation set for predicting gastritis prognosis. Conclusion: The Nomogram model constructed in this study based on baseline data, inflammation indicators and infectious pathogens can effectively predict the prognosis of patients with gastritis, which can provide a powerful reference for clinical individualized treatment decision-making.
Keywords: Gastritis, Inflammatory reactions, Infectious pathogens, Helicobacter pylori, Nomogram model, Validation
Received: 22 Dec 2024; Accepted: 11 Jul 2025.
Copyright: © 2025 Zhang, Yang, Meng, Zhang, Zhu, Yang and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yongmei Qin, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.